Loading company…
The supplied description identifies BioMarin as a developer and commercializer of biopharmaceuticals.
The supplied description concerns BioMarin, which develops and commercializes biopharmaceuticals for serious diseases and medical conditions. Its approved products include Naglazyme, Aldurazyme, Kuvan Tablets and Firdapse.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in